Synthesis of Polysubstituted Pyrroles
Letters in Organic Chemistry, 2009, Vol. 6, No. 5
361
with a saturated solution of NaCl, drying (MgSO4),
evaporation and then column chromatography on silicagel
(CH2Cl2/AcOEt 10:1) provided 9a (50 mg, 40%) as an oil.
Compounds 9b,c and 10a,b were obtained in similar
conditions with slight modifications. Preparation of
compounds 11a-c were carried out from 3.0 mmol of
TosMIC and 6.3 mmol of n-BuLi in analogous conditions.
The reaction mixture was stirred for 5 min then Ph3SnCl (6.0
mmol) in THF was added, and then, after 5 min more, enone
6a, 6b or 5' (2.8 mmol). The reaction was slowly allowed to
warm up to room temperature overnight before hydrolysis.
Data for new compounds, 6a: 1H NMR (200 MHz, CDCl3)
ꢀ 6.76 (1H, dt, J = 16.1, 4.9 Hz), 6.20 (1H, dt, J = 16.1, 1.5
Hz), 4.78 (1H, br s), 3.93 (2H, m), 2.59 (2H, q, J = 7.3 Hz),
1.46 (9H, s), 1.10 (3H, t, J = 7.3 Hz). 13C NMR (50 MHz,
128.2, 128.0, 127.8, 125.4, 121.0, 72.2, 64.9, 33.5, 8.4.
HRMS (DCI+/CH4) calcd for C33H32NO2Sn (M + H)+:
594.1455, found 594.1499. 11c: Mp 103°C. H NMR (400
MHz, CDCl3) ꢀ 8.21 (1H, br s), 7.73-7.25 (15H, m), 6.71
(1H, s), 2.81 (2H, q, J = 7.3 Hz), 2.34 (3H, s), 1.12 (3H, t, J
= 7.3 Hz). 13C NMR (100 MHz, CDCl3) ꢀ 198.3, 139.1,
138.5, 137.2, 133.4, 128.7, 128.4, 123.4, 119.8, 34.1, 13.2,
8.4. HRMS (CI+/NH3) calcd for C20H20NOSn (M - C6H5)+:
410.0567, found 410.0574.
1
CONCLUSION
Finally the sequence exposed above is efficient to
prepare several pyrrole compounds polysubstituted with
functional groups. Thanks to the facile access to the Michael
acceptors by cross metathesis reaction, compounds 9a,b,
10a,b and 11a-c were thus obtained in two steps only. The
combination of the Grubbs procedure with the Van Leusen
TosMIC preparation which is described here enhance the
interest of the latter for the synthesis of complexe pyrroles.
CDCl3) ꢀ 200.6, 155.7, 142.5, 129.2, 79.8, 41.5, 33.4, 28.3,
.
7.9. HRMS (FI+) calcd for C11H19NO3 [M]+ : 213.1365,
1
found 213.1362. 6b: H NMR (200 MHz, CDCl3) ꢀ 7.40-
7.10 (5H, m), 6.84 (1H, dt, J = 15.9, 4.5 Hz), 6.39 (1H, dt, J
= 15.9, 2.0 Hz), 4.57 (2H, s), 4.20 (2H, dd, J = 4.5, 2.0 Hz),
2.59 (2H, q, J = 7.3 Hz), 1.10 (3H, t, J = 7.3 Hz). 13C NMR
(50 MHz, CDCl3) ꢀ 200.7, 141.8, 137.7, 129.1, 128.5, 127.9,
127.7, 72.9, 68.9, 33.7, 8.0. HRMS (FI+) calcd for C13H16O2
ACKNOWLEDGEMENT
.
1
[M]+ : 204.1150, found 204.1145. 9a: H NMR (200 MHz,
CDCl3) ꢀ 9.26 (1H, m), 7.39 (1H, dd, J = 3.2, 2.0 Hz), 6.60
(1H, m), 6.01 (1H, m), 4.26 (2H, d, J = 6.3 Hz), 2.80 (2H, q,
J = 7.3 Hz) 1.41 (9H, s), 1.19 (3H, t, J = 7.3 Hz). 13C NMR
(50 MHz, CDCl3) ꢀ 198.2, 156.5, 125.5, 122.8, 121.9, 119.2,
We thank the local section of Sarthe of the Ligue
Nationale contre le Cancer for a fellowship to C. P.
REFERENCES
79.0, 36.7, 32.5, 28.5, 8.8. HRMS (FI+) calcd for
.
[1]
[2]
[3]
[4]
[5]
Doyle, T.W.; Balitz, D.M.; Grulich, R.E.; Nettleton, D.E.; Gould S.
J.; Tann, C.-H.; Moews, A.E. Tetrahedron Lett., 1981, 22, 4595.
Balitz, D.M.; Bush, J.A.; Bradner, W.T.; Doyle, T.W.; O’Herron,
F.A.; Nettleton, D.E. J. Antibiot., 1982, 35, 259.
Riou, J.-F.; Helissey, P.; Grondard, L.; Giorgi-Renault, S. Mol.
Pharmacol., 1991, 40, 699.
C13H20N2O3: 252.1474 [M]+ , found 252.1428. 9b: Mp 89°C.
1H NMR (400 MHz, CDCl3) ꢀ 9.04 (1H, br s), 7.40-7.24
(5H, m), 7.19 (1H, dd, J = 3.3, 2.0 Hz), 6.69 (1H, m), 4.80
(2H, d, J = 1.0 Hz), 4.64 (2H, s), 2.73 (2H, q, J = 7.3 Hz),
1.15 (3H, t, J = 7.3 Hz). 13C NMR (50 MHz, CDCl3) ꢀ 199.7,
Barbier, C.; Joissains, A.; Commerçon, A.; Riou, J.-F.; Huet, F.
Heterocycles, 2000, 53, 37.
138.6, 128.4, 128.0, 127.6, 125.1, 122.4, 121.9, 119.0, 72.7,
.
66.0, 32.7, 8.8. HRMS (FI+) calcd for C15H17NO2 [M]+ :
a) Nourry, A.; Legoupy, S.; Huet, F. Tetrahedron Lett., 2007, 48,
6014; b) Nourry, A.; Legoupy, S.; Huet, F. Tetrahedron, 2008, 64,
2241.
1
243.1259, found 243.1261. 11a: Mp 112°C. H NMR (200
[6]
a) Gilchrist, T.L. Heterocyclic Chemistry, 3rd ed.; Longman
MHz, CDCl3) ꢀ 8.31 (1H, br s), 7.70-7.25 (15H, m), 6.89
(1H, d, J = 2.1 Hz), 4.83 (1H, br s), 4.44 (2H, d, J = 5.3 Hz)
2.78 (2H, q, J = 7.3 Hz), 1.45 (9H, s), 1.07 (3H, t, J = 7.3
Hz). 13C NMR (50 MHz, CDCl3) ꢀ 198.1, 155.7, 152.2,
139.4, 138.6, 137.6, 137.2, 136.8, 132.2, 130.0, 129.2, 129.1,
129.0, 128.7, 128.4, 128.1, 124.0, 121.8, 79.5, 37.8, 33.9,
28.5, 8.4. HRMS (DCI+/CH4) calcd for C25H29N2O3Sn (M –
C6H5)+: 525.1200, found 525.1192. 11b: Mp 141°C. 1H
NMR (200 MHz, CDCl3) ꢀ 8.31 (1H, br s), 7.74-7.25 (20 H,
m), 6.95 (1H, d, J = 1.9 Hz), 4.63 (2H, s), 4.57 (2H, s), 2.91
(2H, q, J = 7.2 Hz), 1.07 (3H, t, J = 7.2 Hz). 13C NMR (50
MHz, CDCl3) ꢀ 198.4, 139.9, 139.0, 138.5, 138.1, 137.7,
137.3, 136.9, 132.8, 129.1, 129.0, 128.8, 128.7, 128.6, 128.5,
Scientific & Technical: Essex, 1997; b) Eicher, T.; Hauptmann, S.
The Chemistry of Heterocyclic Compounds, 2nd ed.; Wiley-VCH:
Weinheim, 2003; c) Schmuck, C.; Rupprecht, D. Synthesis, 2007,
3095.
[7]
a) Grubbs, R. H.; Chang S. Tetrahedron, 1998, 54, 4413; b)
Grubbs, R.H. Tetrahedron, 2004, 60, 7117; c) Chatterjee, A.K.;
Choi, T.-L.; Sanders, D. P.; Grubbs, R.H. J. Am. Chem. Soc., 2003,
125, 11360.
[8]
[9]
van Leusen, D.; van Leusen, A.M. Org. React., 2001, 57, 419.
a) Dijkstra, H.P.; ten Have, R.; van Leusen, A.M. J. Org. Chem.,
1998, 63, 5332; b) van Nispen, S.P.J.M.; Mensink, C.; van Leusen,
A.M. Tetrahedron Lett., 1980, 21, 3723.